Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight

The wet AMD market is expected to grow due to the increasing diagnosed cases of Wet-AMD, the current therapies, and the launch of emerging therapies such as Ixoberogene soroparvovec (Ixo-vec) (Adverum Biotechnologies), Surabgene lomparvovec (RGX-314) (Regenxb…